Literature DB >> 24059984

Labor induction outcomes in third-trimester stillbirths.

Lori M Gawron1, Jessica W Kiley.   

Abstract

OBJECTIVE: To describe the management of third-trimester stillbirth at a single institution, stratifying induction intervals and adverse outcomes by method.
METHODS: Women diagnosed with fetal demise at 28weeks or later and admitted to an academic hospital between January 2007 and September 2010 were identified. A chart review extracted demographics, history, induction method, delivery interval, and adverse outcomes.
RESULTS: Seventy-four women were included, with a median gestational age of 35.5weeks (range, 28-40weeks). Ten women had undergone at least 1 prior cesarean. Induction methods included misoprostol alone or for cervical ripening; oxytocin and amniotomy; transcervical Foley catheter; and mifepristone. Overall, 88% of patients delivered within 24hours; median time to fetal delivery was 11hours 20minutes (range, 7minutes to 57hours 12minutes). Adverse outcomes included intrapartum fever and postpartum hemorrhage. In total, 98% of patients, including those with prior cesarean, had a successful vaginal delivery.
CONCLUSION: Regardless of third-trimester induction method for management of stillbirth, the majority of women experience safe delivery within 24hours. The descriptive data imply that misoprostol-only inductions might confer the shortest induction intervals; however, further prospective trials are needed to identify the optimal misoprostol regimen for women with third-trimester stillbirth.
© 2013.

Entities:  

Keywords:  Fetal demise; Induction; Misoprostol; Stillbirth; Third trimester

Mesh:

Substances:

Year:  2013        PMID: 24059984     DOI: 10.1016/j.ijgo.2013.06.023

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  1 in total

1.  Current Practices of Cervical Ripening and Induction of Labour in Intrauterine Foetal Demise: An Observational Study.

Authors:  Kinnari V Amin; Anahita R Chauhan; Anchal Goel
Journal:  J Obstet Gynaecol India       Date:  2018-01-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.